JXK-86209-02263
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 220 / VA
- Registered
- 2022-06-21
- Relationship
- Child or adolescent in my care
- Guardian
- JKG-32518-07353
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-21
Registered in v-safe
-
2022-06-22
Dose 1 — Moderna
- 2022-06-22
- 2022-06-23
- 2022-06-24
- 2022-06-25
- 2022-06-26
- 2022-06-27
- 2022-06-28
- 2022-06-29
-
2022-07-06
Survey response — day 14, dose 1, under 3MedDRA: Injection site reaction, Rash erythematous — Feeling: GoodFree text: (b)(6) developed a red rash around his injection site on Friday July 1. It lasted around 24 hours.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-13
-
2022-07-20
Dose 2 — Moderna
- 2022-07-20
-
2022-07-21
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-07-22
-
2022-07-23
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-08-03
- 2022-08-10
- 2022-08-17
- 2022-08-24
- 2022-08-31
-
2022-10-19
Survey response — 3 months, dose 2, under 3MedDRA: Cough, Diarrhoea, Nasopharyngitis, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: He's had a cold with cough and a fever. Rapid tests negative. Had diarrhea at one point as wellMedDRA releases: 2024-11 · check-in free text available
-
2022-12-13
Dose 3 — Moderna
- 2022-12-13
- 2022-12-14
- 2022-12-15
- 2022-12-16
- 2022-12-17
-
2022-12-18
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-12-20
- 2023-01-03
- 2023-01-10
- 2023-01-17
- 2023-01-24
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-20 | Moderna | No |
| 3 | 2022-12-13 | Moderna | No |
Free text
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: (b)(6) developed a red rash around his injection site on Friday July 1. It lasted around 24 hours.
redacted (b)(6)
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: He's had a cold with cough and a fever. Rapid tests negative. Had diarrhea at one point as well
Release 12 (Under 3) — days 1–6 daily, dose 3, under 3
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Injection site reaction | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash erythematous | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release